APO RESEARCH · REPORT
Stem Cell Banking
Stem Cell Banking refers to the human stem cell transplantation for the purpose, with acquisition, processing, preservation and provides the ability to differentiate stem cell storage bank, has been called the "life bank". Storage per Year means the new storage of one year.
Product & engineering
Understand the product.
Stem Cell Banking refers to the human stem cell transplantation for the purpose, with acquisition, processing, preservation and provides the ability to differentiate stem cell storage bank, has been called the "life bank". Storage per Year means the new storage of one year.
Selected research
Industry Research
Stem Cell Banking Industry Research Report 2026
Market perspective
Stem Cell Banking refers to the human stem cell transplantation for the purpose, with acquisition, processing, preservation and provides the ability to differentiate stem cell storage bank, has been called the "life bank". Storage per Year means the new storage of one year.
Global Stem Cell Banking key players include CCBC, CBR, ViaCord, Vcanbio, cells4life, etc. Global top five manufacturers hold a share about 35%. Asia-Pacific is the largest market, with a share about 40%, followed by North America, with a share about 30 percent. In terms of product, Umbilical Cord Blood Stem Cell is the largest segment, with a share about 60%. And in terms of application, the largest application is Diseases Therapy, followed by Healthcare.
Report Scope
Read the full market overview
This report quantifies the global Stem Cell Banking market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Stem Cell Banking Market by Company
CCBC
CBR
ViaCord
Esperite
Vcanbio
Boyalife
LifeCell
Crioestaminal
RMS Regrow
Cordlife
PBKM FamiCord
cells4life
Beikebiotech
StemCyte
Cryo-cell
Cellsafe Biotech
PacifiCord
Americord
Krio
Familycord
Cryo Stemcell
Stemade Biotech
Stem Cell Banking Segment by Type
Umbilical Cord Blood Stem Cell
Embryonic Stem Cell
Adult Stem Cell
Other
Stem Cell Banking Segment by Application
Diseases Therapy
Healthcare
Stem Cell Banking Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Stem Cell Banking market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Stem Cell Banking and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Stem Cell Banking.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Stem Cell Banking manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Stem Cell Banking by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Stem Cell Banking in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Umbilical Cord Blood Stem Cell
- Embryonic Stem Cell
- Adult Stem Cell
- Other
Applications
- Diseases Therapy
- Healthcare
Companies covered
- CCBC
- CBR
- ViaCord
- Esperite
- Vcanbio
- Boyalife
- LifeCell
- Crioestaminal
- RMS Regrow
- Cordlife
- PBKM FamiCord
- cells4life
- Beikebiotech
- StemCyte
- Cryo-cell
- Cellsafe Biotech
- PacifiCord
- Americord
- Krio
- Familycord
- Cryo Stemcell
- Stemade Biotech
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Stem Cell Banking Market Size (2021-2032)
- 2.2.2 Global Stem Cell Banking Sales (2021-2032)
- 2.2.3 Global Stem Cell Banking Market Average Price (2021-2032)
- 2.3 Stem Cell Banking by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Umbilical Cord Blood Stem Cell
- 2.3.3 Embryonic Stem Cell
- 2.3.4 Adult Stem Cell
- 2.3.5 Other
- 2.4 Stem Cell Banking by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Diseases Therapy
- 2.4.3 Healthcare
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Stem Cell Banking Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Stem Cell Banking Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Stem Cell Banking Revenue of Manufacturers (2021-2026)
- 3.4 Global Stem Cell Banking Average Price by Manufacturers (2021-2026)
- 3.5 Global Stem Cell Banking Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Stem Cell Banking, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Stem Cell Banking, Product Type & Application
- 3.8 Global Manufacturers of Stem Cell Banking, Established Date
- 3.9 Global Stem Cell Banking Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 CCBC
- 4.1.1 CCBC Company Information
- 4.1.2 CCBC Business Overview
- 4.1.3 CCBC Stem Cell Banking Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 CCBC Stem Cell Banking Product Portfolio
- 4.1.5 CCBC Recent Developments
- 4.2 CBR
- 4.2.1 CBR Company Information
- 4.2.2 CBR Business Overview
- 4.2.3 CBR Stem Cell Banking Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 CBR Stem Cell Banking Product Portfolio
- 4.2.5 CBR Recent Developments
- 4.3 ViaCord
- 4.3.1 ViaCord Company Information
- 4.3.2 ViaCord Business Overview
- 4.3.3 ViaCord Stem Cell Banking Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 ViaCord Stem Cell Banking Product Portfolio
- 4.3.5 ViaCord Recent Developments
- 4.4 Esperite
- 4.4.1 Esperite Company Information
- 4.4.2 Esperite Business Overview
- 4.4.3 Esperite Stem Cell Banking Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Esperite Stem Cell Banking Product Portfolio
- 4.4.5 Esperite Recent Developments
- 4.5 Vcanbio
- 4.5.1 Vcanbio Company Information
- 4.5.2 Vcanbio Business Overview
- 4.5.3 Vcanbio Stem Cell Banking Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Vcanbio Stem Cell Banking Product Portfolio
- 4.5.5 Vcanbio Recent Developments
- 4.6 Boyalife
- 4.6.1 Boyalife Company Information
- 4.6.2 Boyalife Business Overview
- 4.6.3 Boyalife Stem Cell Banking Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Boyalife Stem Cell Banking Product Portfolio
- 4.6.5 Boyalife Recent Developments
- 4.7 LifeCell
- 4.7.1 LifeCell Company Information
- 4.7.2 LifeCell Business Overview
- 4.7.3 LifeCell Stem Cell Banking Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 LifeCell Stem Cell Banking Product Portfolio
- 4.7.5 LifeCell Recent Developments
- 4.8 Crioestaminal
- 4.8.1 Crioestaminal Company Information
- 4.8.2 Crioestaminal Business Overview
- 4.8.3 Crioestaminal Stem Cell Banking Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Crioestaminal Stem Cell Banking Product Portfolio
- 4.8.5 Crioestaminal Recent Developments
- 4.9 RMS Regrow
- 4.9.1 RMS Regrow Company Information
- 4.9.2 RMS Regrow Business Overview
- 4.9.3 RMS Regrow Stem Cell Banking Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 RMS Regrow Stem Cell Banking Product Portfolio
- 4.9.5 RMS Regrow Recent Developments
- 4.10 Cordlife
- 4.10.1 Cordlife Company Information
- 4.10.2 Cordlife Business Overview
- 4.10.3 Cordlife Stem Cell Banking Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Cordlife Stem Cell Banking Product Portfolio
- 4.10.5 Cordlife Recent Developments
- 4.11 PBKM FamiCord
- 4.11.1 PBKM FamiCord Company Information
- 4.11.2 PBKM FamiCord Business Overview
- 4.11.3 PBKM FamiCord Stem Cell Banking Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 PBKM FamiCord Stem Cell Banking Product Portfolio
- 4.11.5 PBKM FamiCord Recent Developments
- 4.12 cells4life
- 4.12.1 cells4life Company Information
- 4.12.2 cells4life Business Overview
- 4.12.3 cells4life Stem Cell Banking Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 cells4life Stem Cell Banking Product Portfolio
- 4.12.5 cells4life Recent Developments
- 4.13 Beikebiotech
- 4.13.1 Beikebiotech Company Information
- 4.13.2 Beikebiotech Business Overview
- 4.13.3 Beikebiotech Stem Cell Banking Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Beikebiotech Stem Cell Banking Product Portfolio
- 4.13.5 Beikebiotech Recent Developments
- 4.14 StemCyte
- 4.14.1 StemCyte Company Information
- 4.14.2 StemCyte Business Overview
- 4.14.3 StemCyte Stem Cell Banking Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 StemCyte Stem Cell Banking Product Portfolio
- 4.14.5 StemCyte Recent Developments
- 4.15 Cryo-cell
- 4.15.1 Cryo-cell Company Information
- 4.15.2 Cryo-cell Business Overview
- 4.15.3 Cryo-cell Stem Cell Banking Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Cryo-cell Stem Cell Banking Product Portfolio
- 4.15.5 Cryo-cell Recent Developments
- 4.16 Cellsafe Biotech
- 4.16.1 Cellsafe Biotech Company Information
- 4.16.2 Cellsafe Biotech Business Overview
- 4.16.3 Cellsafe Biotech Stem Cell Banking Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Cellsafe Biotech Stem Cell Banking Product Portfolio
- 4.16.5 Cellsafe Biotech Recent Developments
- 4.17 PacifiCord
- 4.17.1 PacifiCord Company Information
- 4.17.2 PacifiCord Business Overview
- 4.17.3 PacifiCord Stem Cell Banking Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 PacifiCord Stem Cell Banking Product Portfolio
- 4.17.5 PacifiCord Recent Developments
- 4.18 Americord
- 4.18.1 Americord Company Information
- 4.18.2 Americord Business Overview
- 4.18.3 Americord Stem Cell Banking Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 Americord Stem Cell Banking Product Portfolio
- 4.18.5 Americord Recent Developments
- 4.19 Krio
- 4.19.1 Krio Company Information
- 4.19.2 Krio Business Overview
- 4.19.3 Krio Stem Cell Banking Sales, Revenue and Gross Margin (2021-2026)
- 4.19.4 Krio Stem Cell Banking Product Portfolio
- 4.19.5 Krio Recent Developments
- 4.20 Familycord
- 4.20.1 Familycord Company Information
- 4.20.2 Familycord Business Overview
- 4.20.3 Familycord Stem Cell Banking Sales, Revenue and Gross Margin (2021-2026)
- 4.20.4 Familycord Stem Cell Banking Product Portfolio
- 4.20.5 Familycord Recent Developments
- 4.21 Cryo Stemcell
- 4.21.1 Cryo Stemcell Company Information
- 4.21.2 Cryo Stemcell Business Overview
- 4.21.3 Cryo Stemcell Stem Cell Banking Sales, Revenue and Gross Margin (2021-2026)
- 4.21.4 Cryo Stemcell Stem Cell Banking Product Portfolio
- 4.21.5 Cryo Stemcell Recent Developments
- 4.22 Stemade Biotech
- 4.22.1 Stemade Biotech Company Information
- 4.22.2 Stemade Biotech Business Overview
- 4.22.3 Stemade Biotech Stem Cell Banking Sales, Revenue and Gross Margin (2021-2026)
- 4.22.4 Stemade Biotech Stem Cell Banking Product Portfolio
- 4.22.5 Stemade Biotech Recent Developments
5 Global Stem Cell Banking Market Scenario by Region
- 5.1 Global Stem Cell Banking Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Stem Cell Banking Sales by Region: 2021-2032
- 5.2.1 Global Stem Cell Banking Sales by Region: 2021-2026
- 5.2.2 Global Stem Cell Banking Sales by Region: 2027-2032
- 5.3 Global Stem Cell Banking Revenue by Region: 2021-2032
- 5.3.1 Global Stem Cell Banking Revenue by Region: 2021-2026
- 5.3.2 Global Stem Cell Banking Revenue by Region: 2027-2032
- 5.4 North America Stem Cell Banking Market Facts & Figures by Country
- 5.4.1 North America Stem Cell Banking Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Stem Cell Banking Sales by Country (2021-2032)
- 5.4.3 North America Stem Cell Banking Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Stem Cell Banking Market Facts & Figures by Country
- 5.5.1 Europe Stem Cell Banking Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Stem Cell Banking Sales by Country (2021-2032)
- 5.5.3 Europe Stem Cell Banking Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Stem Cell Banking Market Facts & Figures by Country
- 5.6.1 Asia Pacific Stem Cell Banking Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Stem Cell Banking Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Stem Cell Banking Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Stem Cell Banking Market Facts & Figures by Country
- 5.7.1 South America Stem Cell Banking Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Stem Cell Banking Sales by Country (2021-2032)
- 5.7.3 South America Stem Cell Banking Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Stem Cell Banking Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Stem Cell Banking Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Stem Cell Banking Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Stem Cell Banking Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Stem Cell Banking Sales by Type (2021-2032)
- 6.1.1 Global Stem Cell Banking Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Stem Cell Banking Sales Market Share by Type (2021-2032)
- 6.2 Global Stem Cell Banking Revenue by Type (2021-2032)
- 6.2.1 Global Stem Cell Banking Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Stem Cell Banking Revenue Market Share by Type (2021-2032)
- 6.3 Global Stem Cell Banking Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Stem Cell Banking Sales by Application (2021-2032)
- 7.1.1 Global Stem Cell Banking Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Stem Cell Banking Sales Market Share by Application (2021-2032)
- 7.2 Global Stem Cell Banking Revenue by Application (2021-2032)
- 7.2.1 Global Stem Cell Banking Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Stem Cell Banking Revenue Market Share by Application (2021-2032)
- 7.3 Global Stem Cell Banking Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Stem Cell Banking Value Chain Analysis
- 8.1.1 Stem Cell Banking Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Stem Cell Banking Production Mode & Process
- 8.2 Stem Cell Banking Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Stem Cell Banking Distributors
- 8.2.3 Stem Cell Banking Customers
9 Global Stem Cell Banking Analyzing Market Dynamics
- 9.1 Stem Cell Banking Industry Trends
- 9.2 Stem Cell Banking Industry Drivers
- 9.3 Stem Cell Banking Industry Opportunities and Challenges
- 9.4 Stem Cell Banking Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst